Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.
暂无分享,去创建一个
K. Geisinger | B. Loggie | R. Fleming | G. Russell | R. McQuellon | R. T. Morris | J. Drees | Debbie Sachs
[1] D. Ross,et al. DT-diaphorase in activation and detoxification of quinones , 1993, Cancer and Metastasis Reviews.
[2] K. Geisinger,et al. Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Disseminated Peritoneal Cancer of Gastrointestinal Origin , 2000, The American surgeon.
[3] T G Myers,et al. DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90. , 1999, Journal of the National Cancer Institute.
[4] D. Ross,et al. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. , 1999, Pharmacogenetics.
[5] H. Klamut,et al. Role of a DT-diaphorase mutation in the response of anal canal carcinoma to radiation, 5-fluorouracil, and mitomycin C. , 1998, International journal of radiation oncology, biology, physics.
[6] K. Geisinger,et al. Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy. , 1997, The American surgeon.
[7] D. Ross,et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). , 1997, British Journal of Cancer.
[8] M. Grever,et al. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. , 1996, Journal of the National Cancer Institute.
[9] J. Fahey,et al. Chemoprotection against cancer by phase 2 enzyme induction. , 1995, Toxicology letters.
[10] P. Workman,et al. Unusually marked hypoxic sensitization to indoloquinone E09 and mitomycin C in a human colon‐tumour cell line that lacks DT‐diaphorase activity , 2007, International journal of cancer.
[11] W. Schulz,et al. Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. , 1994, Biological chemistry Hoppe-Seyler.
[12] D. Ross,et al. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases. , 1994, Cancer research.
[13] M. Nishiyama,et al. Relevance of DT‐diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: Differences in in vitro and in vivo systems , 2009, International journal of cancer.
[14] A. Malkinson,et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł. , 1992, Cancer research.
[15] G. Adams,et al. The sensitivity of human tumour cells to quinone bioreductive drugs: what role for DT-diaphorase? , 1992, Biochemical pharmacology.
[16] P. Workman,et al. DT-diaphorase and cancer chemotherapy. , 1992, Biochemical pharmacology.
[17] K. Danenberg,et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. , 1992, Cancer research.
[18] T. Cresteil,et al. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. , 1991, Biochemical pharmacology.
[19] A. Dulhanty,et al. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase. , 1991, Cancer research.
[20] D. Ross,et al. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. , 1990, Cancer research.
[21] G. Powis,et al. Cytosolic NAD(P)H:(Quinone‐acceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol , 1990, International journal of cancer.
[22] S. Keyes,et al. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. , 1985, Cancer research.
[23] Y. Edwards,et al. Human FAD-dependent NAD(P)H diaphorase. , 1980, The Biochemical journal.
[24] L. Ernster,et al. DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties. , 1962, Biochimica et biophysica acta.
[25] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[26] P. Siekevitz,et al. Soluble Diaphorase in Animal Tissues. , 1958 .